Record Point is an independent corporate advisory firm specialising in domestic and international advisory services for public and private companies.

Record Point advises on the successful sale of Clifford Hallam Healthcare

On 26 November 2015, the majority shareholders of Clifford Hallam Healthcare (“CH2”), ASX-listed Australian Pharmaceutical Industries Limited (“API”) and Allegro Funds (“Allegro”) announced that they had entered into an agreement to sell their shareholdings in the Company.

CH2 is Australia’s largest integrated distributor of pharmaceutical and medical consumable products to the domestic healthcare market. The Company supplies more than 50,000 products to over 20,000 customers, operating across four core business units: Hospitals, Aged Care & Community, Primary Care and Veterinary.

API and Allegro’s shareholdings have been acquired by two former CH2 CEOs and long-term shareholders who are experienced healthcare executives with a deep understanding of CH2’s business model, its customers, suppliers and capabilities.

The sale completed on 1 December 2015.

Record Point acted as the exclusive financial advisor to CH2.